Hong Kong Construction Stock News

As global markets navigate a complex landscape marked by mixed performances in major indices and economic data, investors are increasingly turning their attention to Asia, where resilient manufacturing activity and strategic policy measures are shaping the investment climate. In this context, identifying undervalued stocks that trade below their estimated fair value can offer opportunities for those seeking to capitalize on potential market inefficiencies.

It's been a mediocre week for Want Want China Holdings Limited ( HKG:151 ) shareholders, with the stock dropping 17% to...

As Asian markets navigate a mixed landscape with resilient manufacturing activity in China and shifting sentiment in Japan, investors are keenly observing opportunities that may arise. Penny stocks, though often overlooked, present unique prospects for those seeking growth potential within smaller or newer companies. Despite their traditional reputation as speculative investments, some penny stocks demonstrate robust financial health and can offer intriguing opportunities for long-term success.

China Life Insurance (SEHK:2628) has approved a final dividend of RMB 0.618 per share, equivalent to HK$0.71060, at its 25 June 2026 AGM, giving investors clearer visibility on upcoming income. See our latest analysis for China Life Insurance. The dividend decision comes after a mixed stretch for China Life Insurance’s share price, with a 12.32% 90 day share price return but a year to date share price return that is down 2.64%. At the same time, the 1 year total shareholder return of 57.67%...

Sino Biopharmaceutical (SEHK:1177) is back in focus after China’s regulators approved Peceleganan Spray and accepted a new drug application for tecotabart vedotin, LM-302. These are two pipeline milestones in infection control and advanced gastric cancer. See our latest analysis for Sino Biopharmaceutical. Despite the drug pipeline progress, Sino Biopharmaceutical’s share price tells a mixed story. The HK$4.62 close reflects a 1-day share price return of 4.76% and a 7-day gain of 8.45%, set...

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) has drawn investor attention after new translational research on its sac-TMT and osimertinib combination for EGFR-mutant non small cell lung cancer was published in the journal Cancer Cell. See our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical. The latest Cancer Cell publication and wider sac-TMT trial updates arrive as Sichuan Kelun-Biotech Biopharmaceutical trades at HK$467.6, with a year to date share price return of 16.72%...

Baijin Life Science Holdings (SEHK:1466) has posted its latest full year update with first half FY 2026 revenue of HK$55.1 million and EPS of HK$0.0028, while trailing twelve month figures show revenue of HK$89.3 million and EPS of HK$0.0449 loss alongside a net loss of HK$37.9 million. The company has seen recent half year revenue move from HK$70.9 million in 1H FY 2025 to HK$64.7 million in 2H FY 2025 and HK$55.1 million in 1H FY 2026, with EPS shifting from a HK$0.0092 loss to HK$0.0083...

What the 5-year China Government Bond Futures Launch Means for HKEX Hong Kong Exchanges and Clearing (SEHK:388) is in focus after regulators set a target launch date of 3 August 2026 for 5-year China Government Bond Futures in Hong Kong, expanding the exchange's fixed-income toolkit. This planned contract sits alongside Stock Connect, Bond Connect, Swap Connect and MSCI China A50 Connect Index Futures. It gives investors in Chinese bonds another way to manage interest rate risk linked to...

GoFintech Quantum Innovation (SEHK:290) has put fresh numbers on the table for FY 2026, with first half revenue of HK$1.0b and basic EPS of HK$0.029 setting the tone for how the year is shaping up. The company has seen revenue move from HK$21.3m in the first half of 2025 to HK$838.9m in the second half of 2025 and then to HK$1.0b in the first half of 2026. Basic EPS has shifted from a loss of HK$0.0017 to a small profit of HK$0.0012 and then HK$0.029 across the same periods, giving investors...

Seven Elements Investment Holdings (SEHK:1660) has reported its FY 2026 first half results with revenue of HK$84.6 million and basic EPS of HK$0.000063, setting a cautious tone for investors tracking its profitability. The company has seen revenue move from HK$110.8 million in the first half of FY 2025 to HK$87.1 million in the second half of FY 2025 and HK$84.6 million in the latest half. Net income shifted from a loss of HK$7.4 million and HK$70.4 million in those prior halves to a profit...

Rongzun International Holdings Group (SEHK:1780) has reported its FY 2026 first half results with revenue of HK$28.6 million and a loss per share of HK$0.016596, while net income excluding extra items came in at a loss of HK$10.29 million. The company has seen recent periods swing between a loss per share of HK$0.01692 on HK$43.34 million of revenue in the first half of FY 2025 and a small profit per share of HK$0.001525 on HK$45.04 million of revenue in the second half. This sets up a mixed...

DL Holdings Group (SEHK:1709) has reported its FY 2026 results with first half revenue of HK$115.7 million and basic EPS of HK$0.13, against a backdrop of 165.4% year over year earnings growth and an 83.3% trailing net profit margin over the last twelve months. The company has seen revenue move from HK$60.1 million in the first half of FY 2025 to HK$104.2 million in the second half and then to HK$115.7 million in the first half of FY 2026, while basic EPS progressed from HK$0.01 to HK$0.09...

Yeebo (International Holdings) (SEHK:259) has reported fresh numbers for FY 2026, with first half revenue of HK$554.3 million and basic EPS of HK$1.31. These results come alongside trailing 12 month EPS of HK$4.20 and net income of about HK$3.9 billion, which was shaped by a previously disclosed HK$2.6 billion one off gain. Over the past reported periods, revenue has moved from HK$527.3 million in 1H FY 2025 to HK$511.2 million in 2H FY 2025 and then to HK$554.3 million in 1H FY 2026. Over...

Cirrus Aircraft Limited recently opened a new multi-million-dollar Duluth Talent Center focused on public-facing community engagement, recruiting, technical and field service maintenance training, and broader workforce development, while also approving a final US$0.12 per share (HK$0.94) dividend and appointing KPMG as its new auditor at the June 26, 2026 AGM. This combination of a centralized talent hub and a confirmed cash dividend highlights how Cirrus is investing in both its people...

Cathay Pacific Airways (SEHK:293) has released unaudited traffic figures for May 2026 and the year to date, giving investors fresh detail on passenger volumes, cargo activity and load factors across its main businesses. See our latest analysis for Cathay Pacific Airways. The latest traffic update comes as Cathay Pacific Airways trades at HK$12.98, with a 7 day share price return of 6.48% and a 90 day share price return of 13.76%, alongside a 1 year total shareholder return of 28.19% that...

As Asian markets navigate a period of volatility, driven by global technology sell-offs and regional economic shifts, investors are keenly observing opportunities for value investment. In such environments, identifying stocks trading below their intrinsic value can present potential for growth, especially when considering factors like strong fundamentals and resilience amidst broader market fluctuations.

Amidst a backdrop of mixed performances in global markets, Asian equities have experienced fluctuations influenced by technology sell-offs and broader economic uncertainties. In this environment, companies with high insider ownership can often signal confidence from those who know the business best.

Asian markets have recently experienced fluctuations, with technology stocks facing sell-offs amid concerns over valuations, while broader economic conditions remain a focal point for investors. For those interested in smaller or newer companies, penny stocks—despite the term's somewhat outdated connotation—continue to present intriguing opportunities. By focusing on firms with solid financial foundations and potential for growth, investors can uncover valuable prospects within this niche...

ITC Properties Group (SEHK:199) has opened FY 2026 with a soft first half, reporting revenue of HK$3.5 million and a basic EPS loss of HK$0.13, while trailing 12 month figures show revenue of HK$406.4 million against a basic EPS loss of HK$0.56. Over the past three reported half years, the company has seen revenue move between HK$4.6 million and HK$384.9 million, with basic EPS losses ranging from HK$0.34 to HK$0.56 as profitability pressure has persisted. For investors, the latest numbers...

Perfect Medical Health Management (SEHK:1830) has posted its latest FY 2026 figures with first half revenue of HK$485.9 million and basic EPS of HK$0.08, alongside net income of HK$94.8 million, setting the stage for a results season where profitability remains firmly in focus. Over recent periods, the company has seen revenue move from HK$620.3 million in 1H FY 2025 to HK$507.6 million in 2H FY 2025 and then to HK$485.9 million in 1H FY 2026. Basic EPS shifted from HK$0.11 to HK$0.05 and...

Want Want China Holdings (SEHK:151) has released its FY 2026 results with second half revenue of C¥13.3b and basic EPS of C¥0.18, while trailing twelve month revenue sits at C¥24.4b and EPS at C¥0.33 as the company balances modest growth expectations with softer profitability. Over the past reported periods, revenue has moved from C¥12.6b in 2H FY 2025 to C¥11.1b in 1H FY 2026 and then to C¥13.3b in 2H FY 2026, with basic EPS shifting from C¥0.21 to C¥0.15 and then to C¥0.18 across the same...

Lenovo Group recently expanded its Hybrid AI Advantage portfolio, unveiling new inference-optimized platforms and agentic AI innovations built with partners including NVIDIA, Intel, Red Hat, and Canonical to help enterprises deploy and manage private AI more efficiently across hybrid environments. By tightly integrating hardware, software, and services into validated architectures that emphasize cost control, security, and faster AI deployment, Lenovo is positioning its AI infrastructure and...

In recent days, Tencent-backed Momenta Global launched a Hong Kong IPO to raise up to US$751 million for AI-focused R&D, while Tencent itself agreed a multi-year DRAM chip supply deal with ChangXin Memory Technologies and expanded Weixin Pay’s reach through a Memorandum of Understanding with New Zealand tourism operator RealNZ. These moves highlight how Tencent is working to secure critical chip supply for its cloud and AI infrastructure while using payments partnerships to deepen the Weixin...

Why China Star Entertainment’s Governance Vote Matters for Investors China Star Entertainment (SEHK:326) drew investor attention after shareholders at the 29 June 2026 AGM approved extensive changes to the company’s bye laws, adopted a new governance framework, and renewed broad share issuance and repurchase mandates. See our latest analysis for China Star Entertainment. The AGM decisions appear to have coincided with a sharp pickup in interest in China Star Entertainment, with the stock...